Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 140
interventional 124
Observational 15
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 66
Drug|placebo 27
Drug|Other 8
Device 7
Other 4
Device|Drug 3
Device|Procedure 2
Biological 1
Device|Drug|placebo 1
Device|placebo 1
Drug|Other|placebo 1
Drug|Procedure 1
Other|placebo 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 87
NA 7
Germany 6
United States|Canada 6
Denmark 3
Canada 2
Korea, Republic of 2
United States|Australia|Canada|France|Germany|Netherlands|New Zealand|Sweden|United Kingdom 2
Austria 1
Bulgaria|Czech Republic|France|Germany|Hungary|Poland|Romania|Russian Federation|Ukraine|United Kingdom 1
Finland 1
France|Russian Federation|Sweden 1
Germany|Sweden|United Kingdom 1
Italy 1
Taiwan 1
United States|Australia|Canada|France|Netherlands|New Zealand|Sweden|United Kingdom 1
United States|Canada|Hungary 1

Sites per Study

Site_count Study_Count
1 66
2 5
3 2
4 3
5 2
6 1
7 5
8 2
9 2
10 3
11 2
12 3
13 1
14 2
15 2
16 1
17 2
20 3
21 1
22 1
23 1
26 2
27 2
28 1
30 1
41 1
47 1
49 1
50 2
60 1
79 1
105 1

Phase

Phase Study_Count
Phase 3 36
Phase 2 30
N/A 19
Phase 4 18
Phase 1 11
Phase 1/Phase 2 5
Early Phase 1 3
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 26
2 57
3 25
4 7
5 2
6 1
8 1
10 1
NA 4

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 15.0 8.00000 6.0000 10.0 10.0000 20.00 50.0000 5.0000
1st Qu. 22.5 13.75000 20.5000 15.0 51.7500 35.75 303.5000 27.0000
Median 30.0 23.50000 25.0000 24.0 114.5000 51.50 474.0000 75.5000
Mean 65.0 45.94444 267.6364 20.6 146.9667 51.50 535.9444 175.4444
3rd Qu. 90.0 55.75000 333.0000 24.0 228.7500 67.25 684.2500 201.2500
Max. 150.0 210.00000 1116.0000 30.0 401.0000 83.00 1522.0000 1421.0000

Trial Group Type

group_type Group_Count
Experimental 132
Placebo Comparator 68
Active Comparator 58
Other 15
NA 4
No Intervention 3
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 89
Single Group Assignment 30
Crossover Assignment 5

Primary Purpose

primary_purpose Study_Count
Treatment 113
Basic Science 3
Other 3
Supportive Care 3
Diagnostic 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 8
Canada 2
Canada|Sweden 1
Denmark 1
France 1
NA 1
Taiwan 1

Sites per Study

Site_count Study_Count
1 14
2 1

Enrollment Metrics

Measure Observational
Min 30
1st Qu 112
Median 206
Mean 2039
3rd Qu 453
Max 20000

Observation Model

observational_model Study_Count
Cohort 7
Case-Only 3
NA 3
Case-Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 10
Cross-Sectional 4
Other 1

Registries

Studies by Country

Country Study_Count
NA 1

Sites per Study

Site_count Study_Count
1 1

Enrollment Metrics

Measure Registries
Min 173229
1st Qu 173229
Median 173229
Mean 173229
3rd Qu 173229
Max 173229

Registry Model

observational_model Study_Count
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 1

Follow-up

target_duration Study_Count
30 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03194698 Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea https://ClinicalTrials.gov/show/NCT03194698 Completed Mayo Clinic 2018-12-06
NCT02749786 Genetic Basis of Rosacea Study (Control) https://ClinicalTrials.gov/show/NCT02749786 Completed Stanford University 2016-08-01
NCT02576860 Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle https://ClinicalTrials.gov/show/NCT02576860 Completed Maruho Co., Ltd. 2017-02-27
NCT03392558 The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea https://ClinicalTrials.gov/show/NCT03392558 Completed Burt’s Bees Inc. 2018-03-31
NCT02601963 Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT02601963 Completed Foamix Ltd. 2016-08-31
NCT03380390 Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea https://ClinicalTrials.gov/show/NCT03380390 Completed Aclaris Therapeutics, Inc. 2018-06-15
NCT01451619 A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155) https://ClinicalTrials.gov/show/NCT01451619 Completed Merck Sharp & Dohme Corp. 2012-04-30
NCT01045551 Open Label Pilot Study of Apremilast in Treatment of Rosacea https://ClinicalTrials.gov/show/NCT01045551 Completed Columbia University 2013-01-31
NCT03352323 An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT03352323 Completed Perrigo Company 2017-12-06
NCT03287791 A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea https://ClinicalTrials.gov/show/NCT03287791 Completed Actavis Inc. 2017-06-22
NCT03263273 Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03263273 Completed Hovione Scientia Limited 2019-03-01
NCT03142451 A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03142451 Completed Foamix Ltd. 2018-09-28
NCT03094403 To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel https://ClinicalTrials.gov/show/NCT03094403 Completed Taro Pharmaceuticals USA 2017-03-31
NCT03079531 Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03079531 Completed Stanford University 2019-01-25
NCT03075891 Oracea Soolantra Association in Patients With Severe Rosacea https://ClinicalTrials.gov/show/NCT03075891 Completed Galderma 2018-02-08
NCT01735201 AGN-199201 for the Treatment of Erythema With Rosacea https://ClinicalTrials.gov/show/NCT01735201 Completed Allergan 2013-05-31
NCT03050086 Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea https://ClinicalTrials.gov/show/NCT03050086 Completed BioPharmX, Inc. 2018-06-19
NCT03048058 Internet Surveys and Their Impact on Adherence for Rosacea https://ClinicalTrials.gov/show/NCT03048058 Completed Wake Forest University Health Sciences 2017-06-30
NCT03035955 Azelaic Acid on Demodex Counts in Rosacea https://ClinicalTrials.gov/show/NCT03035955 Completed Wake Forest University Health Sciences 2012-02-02
NCT03003104 DMT210 Topical Gel in the Treatment of Acne Rosacea https://ClinicalTrials.gov/show/NCT03003104 Completed Dermata Therapeutics 2017-08-30
NCT02132117 Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT02132117 Completed Allergan 2015-04-30
NCT02840461 Clinical Endpoint Study of Ivermectin 1% Cream https://ClinicalTrials.gov/show/NCT02840461 Completed Actavis Inc. 2016-11-30
NCT02828241 A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 https://ClinicalTrials.gov/show/NCT02828241 Completed Dr. Reddy’s Laboratories Limited 2017-01-31
NCT01398280 Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation https://ClinicalTrials.gov/show/NCT01398280 Completed University of California, San Diego 2012-12-31
NCT02616250 MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. https://ClinicalTrials.gov/show/NCT02616250 Completed Galderma 2016-09-30
NCT02583009 A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea https://ClinicalTrials.gov/show/NCT02583009 Completed Amorepacific Corporation 2016-08-31
NCT02576847 Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel https://ClinicalTrials.gov/show/NCT02576847 Completed Maruho Co., Ltd. 2017-07-14
NCT02547441 Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle https://ClinicalTrials.gov/show/NCT02547441 Completed Maruho Co., Ltd. 2017-07-05
NCT02028286 A 21 Day Pharmacokinetics Study in Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT02028286 Completed Maruho Co., Ltd. 2014-03-31
NCT02393937 A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea https://ClinicalTrials.gov/show/NCT02393937 Completed bioRASI, LLC 2015-07-31
NCT02385240 Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea https://ClinicalTrials.gov/show/NCT02385240 Completed Perrigo Company 2015-12-31
NCT02300129 Effect of CD07805/47 Gel in Rosacea Flushing https://ClinicalTrials.gov/show/NCT02300129 Completed Galderma R&D 2014-06-30
NCT02289352 Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT02289352 Completed Actavis Inc. 2014-12-31
NCT02268474 Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT02268474 Completed Cutera Inc. 2015-08-31
NCT02249065 Mirvaso in Use Study https://ClinicalTrials.gov/show/NCT02249065 Completed Galderma Laboratories, L.P. 2015-08-31
NCT03276936 A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03276936 Completed Foamix Ltd. 2019-01-03
NCT02147691 Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study https://ClinicalTrials.gov/show/NCT02147691 Completed Derm Research, PLLC 2015-01-31
NCT02144181 Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea https://ClinicalTrials.gov/show/NCT02144181 Completed Merz North America, Inc. 2015-12-31
NCT02131636 Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT02131636 Completed Allergan 2014-11-30
NCT02120924 A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea https://ClinicalTrials.gov/show/NCT02120924 Completed Actavis Inc. 2014-09-30
NCT02095158 A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT02095158 Completed Allergan 2015-08-31
NCT01308619 Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo https://ClinicalTrials.gov/show/NCT01308619 Completed Galderma Laboratories, L.P. 2012-08-31
NCT02052999 Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients https://ClinicalTrials.gov/show/NCT02052999 Completed Amorepacific Corporation 2013-06-30
NCT03841032 4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness https://ClinicalTrials.gov/show/NCT03841032 Completed Bayer 2019-02-25
NCT01993446 A Safety and Efficacy Study of DRM02 in Subjects With Rosacea https://ClinicalTrials.gov/show/NCT01993446 Completed Dermira, Inc. 2014-02-28
NCT01872715 Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea https://ClinicalTrials.gov/show/NCT01872715 Completed Galderma Laboratories, L.P. 2013-06-30
NCT01789775 Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea https://ClinicalTrials.gov/show/NCT01789775 Completed Galderma R&D 2013-10-31
NCT01784133 A Twelve Week Safety and Efficacy Study in Rosacea https://ClinicalTrials.gov/show/NCT01784133 Completed Maruho Co., Ltd. 2014-03-31
NCT01756027 Feasibility Study: Ulthera System for the Treatment of Rosacea https://ClinicalTrials.gov/show/NCT01756027 Completed Merz North America, Inc. 2013-05-31
NCT01740934 A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea https://ClinicalTrials.gov/show/NCT01740934 Completed Rock Creek Pharmaceuticals, Inc. 2013-08-31
NCT01666509 Efficacy and Tolerability of Topical Rossoseqâ„¢ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic) https://ClinicalTrials.gov/show/NCT01666509 Completed PBB Entrepreneur Ltd. 2012-12-31
NCT01618864 Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea https://ClinicalTrials.gov/show/NCT01618864 Completed Syneron Medical 2012-12-31
NCT01631656 Combination Gel and Vascular ND in Mild to Moderate Rosacea https://ClinicalTrials.gov/show/NCT01631656 Completed Wake Forest University Health Sciences 2011-02-28
NCT01579084 Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT01579084 Completed Allergan 2012-06-30
NCT01555463 Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT01555463 Completed LEO Pharma 2014-01-31
NCT01513863 A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea https://ClinicalTrials.gov/show/NCT01513863 Completed Taro Pharmaceuticals USA 2012-06-30
NCT01493947 CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study https://ClinicalTrials.gov/show/NCT01493947 Completed Galderma R&D 2013-12-31
NCT01493687 Phase 3 Papulopustular Rosacea Study https://ClinicalTrials.gov/show/NCT01493687 Completed Galderma 2013-07-31
NCT01318733 Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT01318733 Completed Galderma 2012-06-30
NCT01449591 Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients https://ClinicalTrials.gov/show/NCT01449591 Completed Novartis 2012-02-29
NCT01426269 Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo https://ClinicalTrials.gov/show/NCT01426269 Completed Galderma Laboratories, L.P. 2013-06-30
NCT01355471 Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT01355471 Completed Galderma 2011-11-30
NCT01355458 Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT01355458 Completed Galderma 2011-09-30
NCT04419259 Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea https://ClinicalTrials.gov/show/NCT04419259 Recruiting Danish Headache Center 2021-03-31
NCT04336163 Skin Imaging to Inform Laser Treatments https://ClinicalTrials.gov/show/NCT04336163 Recruiting University of California, Irvine 2020-12-31
NCT02795117 Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea https://ClinicalTrials.gov/show/NCT02795117 Completed Perrigo Company 2017-02-28
NCT04153188 Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea https://ClinicalTrials.gov/show/NCT04153188 Recruiting Candela Corporation 2022-01-31
NCT04108897 Analysis of the Microbiome in Rosacea https://ClinicalTrials.gov/show/NCT04108897 Active, not recruiting Johns Hopkins University 2022-09-30
NCT04106726 Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea https://ClinicalTrials.gov/show/NCT04106726 Active, not recruiting Zydus Worldwide DMCC 2020-07-31
NCT03989492 Role of the Sympathetic Nervous System in Rosacea https://ClinicalTrials.gov/show/NCT03989492 Recruiting Indiana University 2020-08-31
NCT02806414 Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. https://ClinicalTrials.gov/show/NCT02806414 Completed University of California, San Diego 2019-07-31
NCT03954444 A Clinical Endpoint Bioequivalence Study of “Oxymetazoline Hydrochloride Cream” https://ClinicalTrials.gov/show/NCT03954444 Completed Actavis Inc. 2020-01-07
NCT03864978 Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test https://ClinicalTrials.gov/show/NCT03864978 Recruiting Alfasigma S.p.A. 2020-04-30
NCT03756389 Evaluation of Topical Application of BMX-010 in Subjects With Rosacea https://ClinicalTrials.gov/show/NCT03756389 Recruiting BioMimetix JV, LLC 2022-09-30
NCT03689010 To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea https://ClinicalTrials.gov/show/NCT03689010 Completed Taro Pharmaceuticals USA 2018-08-09
NCT03667222 Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03667222 Active, not recruiting BioPharmX, Inc. 2019-05-17
NCT03655197 Lipidome and Microbiome Profile of the Eye in Rosacea https://ClinicalTrials.gov/show/NCT03655197 Active, not recruiting University of California, Davis 2021-01-31
NCT03340961 A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules https://ClinicalTrials.gov/show/NCT03340961 Completed Dr. Reddy’s Laboratories Limited 2018-11-07
NCT03590366 A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea https://ClinicalTrials.gov/show/NCT03590366 Completed AOBiome LLC 2019-02-11
NCT03564145 A Long Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03564145 Completed Sol-Gel Technologies, Ltd. 2020-01-24
NCT03564119 A Study of S5G4T-1 in the Treatment of Papular-Pustular Rosacea https://ClinicalTrials.gov/show/NCT03564119 Completed Sol-Gel Technologies, Ltd. 2019-06-30
NCT03478436 Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers https://ClinicalTrials.gov/show/NCT03478436 Completed Medical University of Vienna 2016-10-25
NCT03472859 Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser https://ClinicalTrials.gov/show/NCT03472859 Completed Tampere University Hospital 2018-06-09
NCT03448939 A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03448939 Completed Sol-Gel Technologies, Ltd. 2019-05-31
NCT03418610 Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT03418610 Completed Clinical Research Center of the Carolinas 2019-01-09
NCT01257919 Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT01257919 Completed LEO Pharma 2011-03-31
NCT01174030 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea https://ClinicalTrials.gov/show/NCT01174030 Completed Galderma 2010-12-31
NCT01186068 Dose Response Study of Patients With Erythematous Rosacea https://ClinicalTrials.gov/show/NCT01186068 Completed Vicept Therapeutics, Inc. NA
NCT01025635 Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT01025635 Completed LEO Pharma 2010-08-31
NCT01016782 Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea https://ClinicalTrials.gov/show/NCT01016782 Completed Fougera Pharmaceuticals Inc. 2009-07-31
NCT00991198 The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage https://ClinicalTrials.gov/show/NCT00991198 Completed Aria Aesthetics Inc. 2010-01-31
NCT00989014 Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea https://ClinicalTrials.gov/show/NCT00989014 Completed Galderma 2009-11-30
NCT00945373 Combination Therapy for the Treatment of Rosacea https://ClinicalTrials.gov/show/NCT00945373 Completed Icahn School of Medicine at Mount Sinai 2010-05-31
NCT00940992 A Study of DER 45-EV Gel to Treat Rosacea https://ClinicalTrials.gov/show/NCT00940992 Completed Sol-Gel Technologies, Ltd. 2012-09-30
NCT00892281 ORCA - Oracea® for Rosacea: A Community-based Assessment https://ClinicalTrials.gov/show/NCT00892281 Completed Galderma Laboratories, L.P. 2009-10-31
NCT00882531 Isotretinoin in Papular-Pustular Rosacea https://ClinicalTrials.gov/show/NCT00882531 Completed Laboratoires Bailleul-Biorga 2009-08-31
NCT00855595 Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT00855595 Completed LEO Pharma 2009-04-30
NCT03878784 PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea https://ClinicalTrials.gov/show/NCT03878784 Completed Danish Headache Center 2019-12-19
NCT02774590 Timolol for the Treatment of Acne and Rosacea https://ClinicalTrials.gov/show/NCT02774590 Recruiting Johns Hopkins University 2025-03-31
NCT01885000 Patient-Reported Outcome Of Facial Erythema (PROOF) https://ClinicalTrials.gov/show/NCT01885000 Completed Galderma 2013-11-30
NCT01529996 Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness https://ClinicalTrials.gov/show/NCT01529996 Completed Northwestern University 2012-08-31
NCT02800148 Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face https://ClinicalTrials.gov/show/NCT02800148 Completed Perrigo Company 2017-10-31
NCT02066051 IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD https://ClinicalTrials.gov/show/NCT02066051 Completed Mayo Clinic 2014-11-30
NCT01933464 An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema https://ClinicalTrials.gov/show/NCT01933464 Completed University of California, San Diego 2014-02-28
NCT01659853 Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea https://ClinicalTrials.gov/show/NCT01659853 Completed Galderma Laboratories, L.P. 2012-12-31
NCT01494467 Phase 3 Papulopustular Rosacea Study https://ClinicalTrials.gov/show/NCT01494467 Completed Galderma 2013-08-31
NCT00697541 Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% https://ClinicalTrials.gov/show/NCT00697541 Completed Galderma 2008-06-30
NCT00681603 Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization https://ClinicalTrials.gov/show/NCT00681603 Completed National Taiwan University Hospital 2008-02-29
NCT00667173 A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea https://ClinicalTrials.gov/show/NCT00667173 Completed Dow Pharmaceutical Sciences 2008-07-31
NCT02075671 Photodynamic Therapy for Papulopustular Rosacea https://ClinicalTrials.gov/show/NCT02075671 Recruiting George Washington University 2019-02-28
NCT00621218 A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea https://ClinicalTrials.gov/show/NCT00621218 Completed Coria Laboratories, Ltd. 2008-04-30
NCT00617903 Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea https://ClinicalTrials.gov/show/NCT00617903 Completed LEO Pharma 2008-06-30
NCT00580723 Effects of PRK 124 Lotion in Acne Rosacea https://ClinicalTrials.gov/show/NCT00580723 Completed University of California, Irvine 2009-02-28
NCT00560703 Treatment of Patients With Blepharitis and Facial Rosacea https://ClinicalTrials.gov/show/NCT00560703 Completed Galderma 2009-05-31
NCT00495313 Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens https://ClinicalTrials.gov/show/NCT00495313 Completed CollaGenex Pharmaceuticals 2007-12-31
NCT00436527 Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application https://ClinicalTrials.gov/show/NCT00436527 Completed Galderma Laboratories, L.P. 2006-08-31
NCT00348335 Efficacy of Topical Cyclosporin for Ocular Rosacea https://ClinicalTrials.gov/show/NCT00348335 Completed Ophthalmic Consultants of Long Island 2007-09-30
NCT00279890 Topical Agent for Treatment of Red Skin https://ClinicalTrials.gov/show/NCT00279890 Completed Mayo Clinic 2007-01-31
NCT00249782 A Phase II, Randomized Study of ACZONEâ„¢ (Dapsone) Gel, 5% for Papulopustular Rosacea. https://ClinicalTrials.gov/show/NCT00249782 Completed Allergan 2006-05-31
NCT00823901 Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea https://ClinicalTrials.gov/show/NCT00823901 Completed Massachusetts General Hospital 2010-10-31
NCT00041977 Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea https://ClinicalTrials.gov/show/NCT00041977 Completed CollaGenex Pharmaceuticals NA
NCT00483145 Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea https://ClinicalTrials.gov/show/NCT00483145 Completed Bispebjerg Hospital NA
NCT00417937 A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily https://ClinicalTrials.gov/show/NCT00417937 Completed LEO Pharma 2007-06-30
NCT00126399 A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea https://ClinicalTrials.gov/show/NCT00126399 Completed CollaGenex Pharmaceuticals NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03193372 A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea https://ClinicalTrials.gov/show/NCT03193372 Completed LEO Pharma 2017-08-08
NCT02787616 Genetic Basis of Rosacea https://ClinicalTrials.gov/show/NCT02787616 Completed Stanford University 2018-11-16
NCT02637232 Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE) https://ClinicalTrials.gov/show/NCT02637232 Completed Galderma 2016-05-31
NCT02292836 Rosacea Prevalence in General Population - Pilot Study https://ClinicalTrials.gov/show/NCT02292836 Completed Galderma 2013-02-28
NCT02292797 Assessment of the Rosacea Prevalence in the General Population https://ClinicalTrials.gov/show/NCT02292797 Completed Galderma 2014-02-28
NCT02270411 Inflammatory Cells From Various Pathologies https://ClinicalTrials.gov/show/NCT02270411 Recruiting Innovaderm Research Inc. 2021-12-31
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01636765 Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale https://ClinicalTrials.gov/show/NCT01636765 Completed Allergan 2012-07-31
NCT04214483 A Pilot Study to Explore the Role of Gut Flora in Acne https://ClinicalTrials.gov/show/NCT04214483 Recruiting ProgenaBiome 2023-03-31
NCT03479853 Clinical, Meibographic and Interferometric Evaluation of Phlyctenular Keratitis in Children - MEIBO-ROSACEE https://ClinicalTrials.gov/show/NCT03479853 Completed Fondation Ophtalmologique Adolphe de Rothschild 2020-03-12
NCT03872050 Deep Phenotyping of Rosacea and Migraine https://ClinicalTrials.gov/show/NCT03872050 Active, not recruiting Danish Headache Center 2020-09-01
NCT04377841 Facial Demodicosis and Ocular Demodicosis https://ClinicalTrials.gov/show/NCT04377841 Recruiting National Taiwan University Hospital 2020-12-14
NCT02602470 Preferences & Treatment Satisfaction Drivers in Rosacea Patients https://ClinicalTrials.gov/show/NCT02602470 Completed LEO Pharma 2016-03-10
NCT00710489 Potential Research Study Participant Registry https://ClinicalTrials.gov/show/NCT00710489 Completed University of California, Davis 2018-09-05
NCT00668655 An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1% https://ClinicalTrials.gov/show/NCT00668655 Completed Galderma Laboratories, L.P. 2008-03-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03253666 Nurses’ Health Study and Health Professionals Follow-Up Study (Dermatological Component) https://ClinicalTrials.gov/show/NCT03253666 Enrolling by invitation Harvard School of Public Health 2020-12-31